Loading clinical trials...
Loading clinical trials...
This study will evaluate the long-term safety and efficacy of onabotulinumtoxinA (botulinum toxin Type A; BOTOX®) for the treatment of urinary incontinence due to neurogenic detrusor overactivity in p...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergan
NCT06798311 · Urinary Incontinence (UI), Lower Urinary Tract Symptoms (LUTS), and more
NCT07489794 · Multiple Sclerosis, Urinary Incontinence (UI)
NCT05362292 · Urinary Incontinence, Urge, Urinary Incontinence, and more
NCT07105150 · Urinary Incontinence
NCT07209397 · Overactive Bladder, Overactive Bladder (OAB), and more
University of Alabama at Birmingham Division of Urology Research Office
Birmingham, Alabama
Cedars-Sinai Medical Center
Los Angeles, California
Children's Hospital of Orange County
Orange, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions